Searle & Co’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $227K | Hold |
2,050
| – | – | 0.06% | 163 |
|
|
2025
Q1 | $230K | Buy |
+2,050
| New | +$230K | 0.07% | 162 |
|
|
2024
Q3 | – | Sell |
-6,750
| Closed | -$463K | – | 180 |
|
|
2024
Q2 | $463K | Buy |
6,750
+2,700
| +67% | +$185K | 0.11% | 113 |
|
|
2024
Q1 | $297K | Hold |
4,050
| – | – | 0.08% | 128 |
|
|
2023
Q4 | $328K | Buy |
+4,050
| New | +$328K | 0.09% | 123 |
|
|
2021
Q1 | – | Sell |
-5,500
| Closed | -$320K | – | 143 |
|
|
2020
Q4 | $320K | Buy |
5,500
+1,300
| +31% | +$75.6K | 0.15% | 107 |
|
|
2020
Q3 | $265K | Buy |
+4,200
| New | +$265K | 0.14% | 111 |
|
|
2018
Q2 | – | Sell |
-13,200
| Closed | -$995K | – | 133 |
|
|
2018
Q1 | $995K | Hold |
13,200
| – | – | 0.65% | 50 |
|
|
2017
Q4 | $946K | Sell |
13,200
-150
| -1% | -$10.8K | 0.59% | 55 |
|
|
2017
Q3 | $1.08M | Hold |
13,350
| – | – | 0.72% | 51 |
|
|
2017
Q2 | $945K | Hold |
13,350
| – | – | 0.65% | 53 |
|
|
2017
Q1 | $907K | Buy |
13,350
+80
| +0.6% | +$5.44K | 0.64% | 52 |
|
|
2016
Q4 | $950K | Sell |
13,270
-1,300
| -9% | -$93.1K | 0.79% | 46 |
|
|
2016
Q3 | $1.13M | Buy |
+14,570
| New | +$1.13M | 0.98% | 38 |
|
|
2016
Q2 | – | Sell |
-14,570
| Closed | -$1.37M | – | 55 |
|
|
2016
Q1 | $1.37M | Buy |
14,570
+220
| +2% | +$20.7K | 1.26% | 27 |
|
|
2015
Q4 | $1.41M | Hold |
14,350
| – | – | 1.35% | 21 |
|
|
2015
Q3 | $1.41M | Hold |
14,350
| – | – | 1.45% | 16 |
|
|
2015
Q2 | $1.68M | Hold |
14,350
| – | – | 1.4% | 16 |
|
|
2015
Q1 | $1.41M | Sell |
14,350
-50
| -0.3% | -$4.91K | 1.21% | 22 |
|
|
2014
Q4 | $1.36M | Buy |
+14,400
| New | +$1.36M | 1.15% | 22 |
|